Skip to main content
logo
Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.500
-0.050 (-1.10%)
At close: Oct 9, 2026, 4:00 PM EDT
4.500
0.00 (0.00%)
Pre-market: Oct 12, 2026, 6:12 AM EDT

Quoin Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
221255715
Market Cap Growth
348.79%127.24%10.02%-29.65%-54.69%-
Enterprise Value
139-2-5-421
Last Close Price
4.5014.4322.77171.68596.409555.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.300.920.580.860.9323.12
P/TBV Ratio
6.010.950.610.951.03-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.520.180.320.620.567.19
Net Debt / Equity Ratio
-2.23-1.25-1.21-1.27-1.18-4.20
Net Debt / EBITDA Ratio
0.461.011.180.770.950.46
Quick Ratio
1.633.383.362.993.641.64
Current Ratio
1.763.613.573.153.791.79
Return on Equity (ROE)
-575.73%-141.59%-120.55%-132.92%-232.68%-
Return on Assets (ROA)
-114.60%-56.41%-42.72%-44.03%-48.59%-70.60%
Return on Capital Employed (ROCE)
-357.40%-109.70%-82.70%-109.20%-84.70%-126.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-86.34%-130.55%-168.23%-179.39%-136.30%-141.27%
Buyback Yield / Dilution
-485.24%-710.69%-411.86%---
SEC Filings: 10-K · 10-Q